Executive VP of Vision Science, Dr. Len Zheleznyak, to present performance data on the world's only diffractive multifocal soft contact lens and new findings on the "Optical Signatures" of myopia ...
ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.
CAMPBELL, Calif.--(BUSINESS WIRE)--Body Vision Medical, a leader in AI-driven, intraoperative image guidance, today announced that its LungVision® system has been selected as the winner of the “Best ...
This breakthrough innovation sets new standards for modern eyewear by combining electro-optics, AI and the expertise of eyecare professionals (ECPs) worldwide. Percept Corporation is introducing ...
Medical Device Network on MSN
ReVision Implant eyes FIH trial for BCI after FDA breakthrough designation
ReVision now anticipates initiating early-stage human clinical trials of its Occular BCI in blind volunteers in 2027.
A BREAKTHROUGH TREATMENT IS HELPING RESTORE SIGHT FOR PATIENTS. IT USES A SIMPLE GEL DOCTORS ALREADY USE, BUT IN AN ENTIRELY NEW WAY.
"CES 2026 marks a defining moment for Dreame as we bring our 'All Dreams in One Dreame' vision to life," said Ana Wang, General Manager of Dreame Technology North America. "From the X60 Max Ultra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results